Xiaoling Yuan Selected Research

Xiaoling Yuan Research Topics

Disease

10	Neoplasms (Cancer) 11/2019 - 03/2006
3	Asthma (Bronchial Asthma) 07/2021 - 01/2021
3	Inflammation (Inflammations) 07/2021 - 08/2017
3	Retinoblastoma (Glioblastoma, Retinal) 01/2020 - 03/2006
3	Carcinogenesis 01/2020 - 08/2006
2	Myocardial Infarction 01/2021 - 04/2015
2	Heart Failure 01/2021 - 01/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 01/2012
2	Hypoxia (Hypoxemia) 01/2019 - 11/2018
2	Respiratory Syncytial Virus Infections 01/2019 - 02/2018
2	Infections 02/2018 - 03/2014
1	Respiratory Insufficiency (Respiratory Failure) 06/2022
1	Critical Illness (Critically Ill) 06/2022
1	Parkinson Disease (Parkinson's Disease) 05/2022
1	Hemorrhage 05/2022
1	Pneumonia (Pneumonitis) 05/2022
1	Sepsis (Septicemia) 05/2022
1	Apnea 01/2022
1	Myalgia 01/2022
1	Obstructive Sleep Apnea 01/2022
1	Rhabdomyolysis 01/2022
1	Fatigue 01/2022
1	Fever (Fevers) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Cognitive Dysfunction 01/2022
1	Psittacosis (Ornithosis) 01/2022
1	Stroke (Strokes) 10/2021
1	Hyperplasia 02/2021
1	Respiratory Hypersensitivity 02/2021
1	Chronic Renal Insufficiency 01/2021
1	Anemia 01/2021
1	Cerebral Infarction 01/2021
1	Multiple System Atrophy 01/2021
1	Disease Progression 01/2021
1	Essential Thrombocythemia 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Glioma (Gliomas) 01/2020
1	Dementia (Dementias) 11/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
4	AntioxidantsIBA 05/2022 - 05/2006
3	EnzymesIBA 05/2022 - 05/2006
3	Oxygen (Dioxygen)IBA 01/2022 - 11/2018
3	Liposomes (Liposome)IBA 11/2019 - 11/2018
3	sulforaphaneIBA 09/2006 - 03/2006
2	Messenger RNA (mRNA)IBA 05/2022 - 03/2006
2	TropomyosinIBA 07/2021 - 02/2021
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 11/2018
2	phosphoprotein C23IBA 01/2019 - 02/2018
2	Toll-Like Receptor 4IBA 01/2019 - 02/2018
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	GoldIBA 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 11/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 03/2014
2	Cyclin D3IBA 07/2007 - 03/2006
2	Retinoblastoma ProteinIBA 07/2007 - 03/2006
2	Cyclin D1IBA 07/2007 - 03/2006
2	Transcription Factors (Transcription Factor)IBA 11/2006 - 05/2006
2	Heme Oxygenase-1IBA 09/2006 - 08/2006
2	NF-E2-Related Factor 2IBA 08/2006 - 05/2006
1	QuinolonesIBA 06/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2022
1	BenserazideIBA 05/2022
1	CatalaseIBA 05/2022
1	MicroRNAs (MicroRNA)IBA 05/2022
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2022
1	Glutathione Peroxidase GPX1IBA 05/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	TeaIBA 01/2022
1	MyoglobinIBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	tectochrysinIBA 07/2021
1	Aluminum Hydroxide (Algeldrate)FDA Link 07/2021
1	Methacholine Chloride (Methacholine)FDA Link 02/2021
1	AluminumIBA 02/2021
1	CollagenIBA 02/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	roxadustatIBA 01/2021
1	Omalizumab (Xolair)FDA Link 01/2021
1	Long Noncoding RNAIBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020

Therapy/Procedure

7	Therapeutics 06/2022 - 06/2012
3	Punctures 05/2022 - 01/2018
3	Chemoprevention 03/2008 - 03/2006
2	Continuous Renal Replacement Therapy 06/2022 - 01/2022
2	Aftercare (After-Treatment) 01/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 11/2018 - 03/2006
2	Immunotherapy 01/2018 - 01/2018
2	Lasers (Laser) 01/2018 - 01/2018
1	Extracorporeal Membrane Oxygenation 06/2022
1	Artificial Respiration (Mechanical Ventilation) 06/2022
1	Ligation 05/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Secondary Prevention 10/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 10/2021
1	Transplantation 01/2021